Search Results - "TOSHIHIRO TAJIMA"

Refine Results
  1. 1

    Genetic causes of central precocious puberty by Toshihiro Tajima

    Published in Clinical Pediatric Endocrinology (01-07-2022)
    “…[Highlights] ●The review clarifies new genetic etiologies of CPP. ●The genetic etiologies are useful for a better understanding of the timing of puberty. ●The…”
    Get full text
    Journal Article
  2. 2

    Newborn Screening in Japan-2021 by Tajima, Toshihiro

    “…Japan's Newborn Mass Screening (NBS) was started in 1977 for amino acid metabolism disorders (phenylketonuria (PKU), homocystinuria, maple syrup urine,…”
    Get full text
    Journal Article
  3. 3

    Genetic causes of central precocious puberty by Tajima, Toshihiro

    Published in Clinical Pediatric Endocrinology (01-01-2022)
    “…Central precocious puberty (CPP) is a condition in which the hypothalamus–pituitary–gonadal system is activated earlier than the normal developmental stage…”
    Get full text
    Journal Article
  4. 4

    Health problems of adolescent and adult patients with 21-hydroxylase deficiency by Tajima, Toshihiro

    Published in Clinical Pediatric Endocrinology (01-01-2018)
    “…Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long steroid…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan by Yatsuga, Shuichi, Amano, Naoko, Nakamura-Utsunomiya, Akari, Kobayashi, Hironori, Takasawa, Kei, Nagasaki, Keisuke, Nakamura, Akie, Nishigaki, Satsuki, Numakura, Chikahiko, Fujiwara, Ikuma, Minamitani, Kanshi, Hasegawa, Tomonobu, Tajima, Toshihiro

    Published in ENDOCRINE JOURNAL (01-01-2020)
    “…Cytochrome P450 oxidoreductase deficiency (PORD) is a disorder of steroidogenesis that causes various symptoms such as skeletal malformations, disorders of sex…”
    Get full text
    Journal Article
  7. 7

    Current status of transition medicine for 21-hydroxylase deficiency in Japan: from the perspective of pediatric endocrinologists by Takasawa, Kei, Nakamura-Utsunomiya, Akari, Amano, Naoko, Ishii, Tomohiro, Hasegawa, Tomonobu, Hasegawa, Yukihiro, Tajima, Toshihiro, Ida, Shinobu

    Published in ENDOCRINE JOURNAL (01-01-2022)
    “…To manage of 21-hydroxylase deficiency (21-OHD), transition medicine from pediatric to adult health care is an important process and requires individually…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A novel nonsense variant (p.Arg1293Ter) of the immunoglobulin superfamily 1 (IGSF1) associated with congenital hypogonadotropic hypogonadism and central hypothyroidism by Toshihiro Tajima, Makiko Oguma

    Published in Clinical Pediatric Endocrinology (01-04-2022)
    “…[Introduction] Individuals with deletions and/or pathogenic variants of the Immunoglobulin superfamily 1 (IGSF1) gene may show congenital central…”
    Get full text
    Journal Article
  10. 10

    Health problems of adolescent and adult patients with 21-hydroxylase deficiency by Toshihiro Tajima

    Published in Clinical Pediatric Endocrinology (01-10-2018)
    “…[Abstract.] Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long…”
    Get full text
    Journal Article
  11. 11

    Treatment of X-Linked Hypophosphatemia in Children by Tajima, Toshihiro, Hasegawa, Yukihiro

    Published in Endocrines (11-08-2022)
    “…The conventional treatment for X-linked hypophosphatemia (XLH), consisting of phosphorus supplementation and a biologically active form of vitamin D…”
    Get full text
    Journal Article
  12. 12

    Acute Perimyocarditis in an Adolescent Japanese Male after a Booster Dose of the BNT162b2 COVID-19 Vaccine by Morita, Yusuke, Matsubara, Daisuke, Seki, Mitsuru, Tamura, Daisuke, Tajima, Toshihiro

    “…Perimyocarditis is a rare and serious cardiac complication following COVID-19 vaccination. Young males are most at risk after the second dose. With the…”
    Get full text
    Journal Article
  13. 13

    Clinical features and molecular basis of pseudohypoaldosteronism type 1 by Tajima, Toshihiro, Morikawa, Shuntaro, Nakamura, Akie

    Published in Clinical Pediatric Endocrinology (01-01-2017)
    “…Pseudohypoaldosteronism (PHA) type 1 is a disease showing mineralocorticoid resistance in the kidney and/or other mineralocorticoid target tissues. Patients…”
    Get full text
    Journal Article
  14. 14

    Neonatal mass screening for 21-hydroxylase deficiency by Tajima, Toshihiro, Fukushi, Masaru

    Published in Clinical Pediatric Endocrinology (01-01-2016)
    “…Congenital adrenal hyperplasia(CAH)due to 21-hydroxylase deficiency (21-OHD) is an inherited autosomal recessive disorder. Its incidence is 1 in 10,000 to…”
    Get full text
    Journal Article
  15. 15

    Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision) by Nagasaki, Keisuke, Minamitani, Kanshi, Nakamura, Akie, Kobayashi, Hironori, Numakura, Chikahiko, Itoh, Masatsune, Mushimoto, Yuichi, Fujikura, Kaori, Fukushi, Masaru, Tajima, Toshihiro

    Published in Clinical Pediatric Endocrinology (2023)
    “…Purpose of developing the guidelines: Newborn screening (NBS) for congenital hypothyroidism (CH) was started in 1979 in Japan, and early diagnosis and…”
    Get full text
    Journal Article
  16. 16

    A novel mutation of IGSF1 in a Japanese patient of congenital central hypothyroidism without macroorchidism [Rapid Communication] by Tajima, Toshihiro, Nakamura, Akie, Ishizu, Katsura

    Published in ENDOCRINE JOURNAL (2013)
    “…Congenital central hypothyroidism (C-CH) is a rare disease known to be caused by mutations of the genes encoding TSH β or the TRH receptor gene, although the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Recent advances in research on isolated congenital central hypothyroidism by Tajima, Toshihiro, Nakamura, Akie, Oguma, Makiko, Yamazaki, Masayo

    Published in Clinical Pediatric Endocrinology (01-01-2019)
    “…Congenital central hypothyroidism (C-CH) is caused by defects in the secretion of thyrotropin-releasing hormone (TRH) and/or TSH, leading to an impairment in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Functional analysis of PAX8 variants identified in patients with congenital hypothyroidism in situ by Batjargal, Khishigjargal, Tajima, Toshihiro, Fujita-Jimbo, Eriko, Yamaguchi, Takeshi, Nakamura, Akie, Yamagata, Takanori

    Published in Clinical Pediatric Endocrinology (2022)
    “…Paired box transcription factor 8 (PAX8) is essential for thyroid organogenesis and development. Heterozygous pathogenic variants of PAX8 typically cause…”
    Get full text
    Journal Article